These results indicate that loss of ASS protein is associated with the anti-proliferative effects of ADI-PEG20 in otherwise identical cells and further validates the relative sensitivities observed in SCLC cancers of differing ASS expression. The gene discussed is ASS1; the disease is small cell lung carcinoma.